Breakdown of the 300 samples sequenced with the ThromboGenomics platform. The width of each box is proportional to the number of individuals it represents. The 4 main categories are shown as labels in italics. The shaded area in each box shows the proportion of samples in which pathogenic or likely pathogenic variants were identified with the ThromboGenomics platform. Note that the mother of a hemophilia A patient from the “suspected” group appears in shading in the box representing the “unaffected” group.